Showing results (1081-1090 of 2,128) with videos related to

Sort By:
Pageof 213
Experimental Hematology|December 14, 2004
A mouse model of lymphocyte infusion-induced bone marrow failureMichael L Bloom, Adam G Wolk, Karen L Simon-Stoos, et al.
Sleep|January 1, 2010
Obstructive sleep apnea and aldosteroneAnna Svatikova, Lyle J Olson, Robert Wolk, et al.
British Journal of Cancer|October 29, 2009
A prospective study of lifetime physical activity and prostate cancer incidence and mortalityN Orsini, R Bellocco, M Bottai, et al.
American Heart Journal|December 17, 2016
Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish MenDaniel A Steinhaus, Elizabeth Mostofsky, Emily B Levitan, et al.
The Journal of Chemical Physics|June 16, 2014
Communication: He-tagged vibrational spectra of the SarGlyH⁺ and H⁺(H₂O)(2,3) ions: quantifying tag effects in cryogenic ion vibrational predissociation (CIVP) spectroscopyChristopher J Johnson, Arron B Wolk, Joseph A Fournier, et al.
Journal of Participatory Medicine|July 31, 2025
Integrating Patient Choice and Collaborative Care Managers to Implement eHealth Tools in Depression: Self-Report Pilot StudyJennifer Severe, Adrienne Lapidos, Danielle S Taubman, et al.
The Journal of Cardiovascular Surgery|July 17, 2001
Upper extremity venous gangrene following coronary artery bypass. A case report and review of the literatureV V Sullivan, S W Wolk, R M Lampman, et al.
Experimental Dermatology|April 19, 2003
Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expressionMartina Seifert, Beate H Gruenberg, Robert Sabat, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 9, 2022
Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registryMeghan Beth Spyres, Gabriel K Padilla, Richard D Gerkin, et al.
Genes and Immunity|October 3, 2009
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesK Witte, G Gruetz, H-D Volk, et al.
Pageof 213